ARDX three-lens brief
Evidence-based stock research on ARDX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.74% yesterday. · Trading at 0% of its 52-week range — deep in the lower band.
- Moved -4.74% yesterday.
- Trading at 0% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- RSI at 28 — technically oversold.
- Underperforming SPY by 31.5pp over 30 days.
ARDX closed at $3.62 (-4.74%) as of 2026-09-11. Market cap: $934.64M. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $12.90 — 256% above current (10 analysts).. Concerns: moved -4.74% yesterday.; trading at 0% of its 52-week range — deep in the lower band.. Last quarter: Revenue $120.88M, net income -$16.72M, free cash flow $20.47M.
Why three lenses on ARDX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARDXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARDX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARDX brief"></iframe>